Patents by Inventor Anthony Hadfield

Anthony Hadfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline solid forms of tigecycline and methods of preparing same
    Publication number: 20070123497
    Abstract: Crystalline solid forms of tigecycline, Form I, Form II, Form III, Form IV, and Form V, compositions comprising these crystalline solid forms, and processes for preparing these crystalline solid forms are described herein.
    Type: Application
    Filed: May 25, 2006
    Publication date: May 31, 2007
    Inventors: Lalitha Krishnan, Subodh Deshmukh, Anthony Hadfield, W. Huang, Mannching Ku
  • Novel succinate salt of O-desmethyl-venlafaxine
    Publication number: 20070037884
    Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Application
    Filed: January 18, 2006
    Publication date: February 15, 2007
    Applicant: Wyeth
    Inventors: Anthony Hadfield, Syed Shah, James Provost
  • Crystalline and amorphous 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride
    Publication number: 20070027162
    Abstract: The present invention is directed to crystal and amorphous forms of the 5-HT1A receptor antagonist 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride, as well as compositions thereof and methods of using the same.
    Type: Application
    Filed: February 27, 2006
    Publication date: February 1, 2007
    Applicant: Wyeth
    Inventors: Eric Browne, Michel Bernatchez, Mark Lankau, Abdolsamad Tadayon, Anthony Hadfield
  • Novel formate salt of O-desmethyl-venlafaxine
    Publication number: 20060058552
    Abstract: A novel salt of O-desmethylvenlafaxine, O-desmethylvenlafaxine formate, is provided. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Application
    Filed: October 21, 2005
    Publication date: March 16, 2006
    Applicant: Wyeth
    Inventors: Anthony Hadfield, Michael Winkley
  • Purification of progesterone receptor modulators
    Publication number: 20050250766
    Abstract: Methods for purifying a compound of formula I are provided, wherein A, B X, Q, and R1 are defined herein. The methods include mixing the compound of formula I and a solvent; adding a base to the solvent; and precipitating purified compound of formula I.
    Type: Application
    Filed: April 25, 2005
    Publication date: November 10, 2005
    Applicant: Wyeth
    Inventors: Bogdan Wilk, Arkadiy Rubezhov, Anthony Hadfield, Jean Helom
  • Novel succinate salt of O-desmethyl-venlafaxine
    Publication number: 20050096479
    Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Application
    Filed: November 10, 2004
    Publication date: May 5, 2005
    Applicant: Wyeth
    Inventors: Anthony Hadfield, Syed Shah, Michael Winkley, Karen Sutherland, James Provost, Aeri Park, Rex Shipplett, Brenton Russell, Beat Weber
  • Response time and resource consumption management in a distributed network environment
    Publication number: 20040103193
    Abstract: Software, systems and methods for managing a distributed network. For a given distributed device, the software includes a transaction monitor configured to identify transaction start times and stop times, and a resource consumption monitor configured to determine how much bandwidth is consumed by the distributed device during performance of a network transaction initiated by the device.
    Type: Application
    Filed: November 7, 2003
    Publication date: May 27, 2004
    Inventors: Suketu J. Pandya, Anthony Hadfield